Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00522002 · ClinicalTrials.gov registry record

CLUE Study: Connective Tissue Disease Leg Ulcer Etiology Study

A clinical trial of Rheumatoid Arthritis and Systemic Lupus Erythematosus, sponsored by George Washington University.

Completed
Registry status
40
Enrollment target
1
Study location

NCT00522002 is a study of Rheumatoid Arthritis and Systemic Lupus Erythematosus that has completed, run by George Washington University. The registered enrollment target is 40 participants, below the 4,690-participant average among 197 other Rheumatoid Arthritis trials with a reported enrollment target (99% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00522002, a study of Rheumatoid Arthritis and Systemic Lupus Erythematosus, has completed, sponsored by George Washington University.

COMPLETED
Registry status
40 participants
Enrollment target
1
Study location

Study Summary

To explore the hypothesis that leg ulcers are associated with hypercoagulable states, the CLUE study will evaluate patients with connective tissue disease associated leg ulcers, to identify risk factors (especially hypercoagulability and immunologic characteristics), characterize pathogenesis, predict response to therapy, and assess the impact of lower extremity ulcers on quality of life.

Study Locations (1)

District of Columbia

  • Victoria Shanmugam - Washington D.C.

Trial Details

FieldValue
Enrollment Target 40 participants
Start Date 2007-08
Est. Completion 2010-06

Sponsor

George Washington University

133 total trials

What the Registry Record Tells You About NCT00522002

The ClinicalTrials.gov registry entry for NCT00522002 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 40 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 4,690-participant average among 197 other Rheumatoid Arthritis trials with a reported enrollment target (99% lower). The listed sponsor is George Washington University, which has 133 total studies on file at ClinicalTrials.gov.

The record links to 7 conditions, with Rheumatoid Arthritis appearing as the primary indexed condition, and to 0 interventions.

NCT00522002 reports 1 study location spanning 1 distinct geographic area - top geographies include District of Columbia.

Frequently Asked Questions

What is clinical trial NCT00522002 about?

NCT00522002 is a clinical study titled "CLUE Study: Connective Tissue Disease Leg Ulcer Etiology Study". To explore the hypothesis that leg ulcers are associated with hypercoagulable states, the CLUE study will evaluate patients with connective tissue disease associated leg ulcers, to identify risk factors (especially hypercoagulability and immunologic characteristics), characterize pathogenesis, predi...

What is the current status of trial NCT00522002?

This trial is currently completed. The enrollment target is 40 participants. The study started on 2007-08. Estimated completion is 2010-06.

What conditions does trial NCT00522002 study?

This clinical trial studies the following conditions: Rheumatoid Arthritis, Systemic Lupus Erythematosus, Blood Coagulation Disorders, Connective Tissue Diseases, Systemic Scleroderma.

Who is sponsoring clinical trial NCT00522002?

This trial is sponsored by George Washington University, which has 133 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT00522002 being conducted?

This trial has 1 study location across District of Columbia. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Rheumatoid Arthritis

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.